Xiaofei Shao

997 total citations
48 papers, 731 citations indexed

About

Xiaofei Shao is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Xiaofei Shao has authored 48 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 19 papers in Endocrinology, Diabetes and Metabolism and 17 papers in Nephrology. Recurrent topics in Xiaofei Shao's work include Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Liver Disease Diagnosis and Treatment (15 papers) and Chronic Kidney Disease and Diabetes (9 papers). Xiaofei Shao is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Liver Disease Diagnosis and Treatment (15 papers) and Chronic Kidney Disease and Diabetes (9 papers). Xiaofei Shao collaborates with scholars based in China, Ireland and United States. Xiaofei Shao's co-authors include Hequn Zou, Hequn Zou, Yan Liang, Harry Holthöfer, Yongqiang Li, Shanying Chen, Chongxiang Xiong, Qin Zhou, Xinyu Liu and Youming Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Xiaofei Shao

45 papers receiving 717 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei Shao China 17 306 276 261 112 106 48 731
Lilin Gong China 15 244 0.8× 273 1.0× 128 0.5× 149 1.3× 81 0.8× 31 700
Jae Hwan Jee South Korea 15 297 1.0× 298 1.1× 123 0.5× 158 1.4× 113 1.1× 35 856
Ei-Ichi Toda Japan 15 308 1.0× 248 0.9× 344 1.3× 306 2.7× 132 1.2× 23 919
Erdim Sertoğlu Türkiye 17 302 1.0× 141 0.5× 100 0.4× 87 0.8× 128 1.2× 61 769
Yiting Xu China 17 202 0.7× 246 0.9× 80 0.3× 123 1.1× 221 2.1× 69 752
Federica Piani Italy 19 121 0.4× 150 0.5× 394 1.5× 114 1.0× 240 2.3× 46 1.0k
Ting Luo China 18 199 0.7× 340 1.2× 165 0.6× 146 1.3× 245 2.3× 47 1.0k
Jenie Yoonoo Hwang South Korea 19 277 0.9× 287 1.0× 56 0.2× 185 1.7× 141 1.3× 34 828
Ihab Wahba United States 8 103 0.3× 101 0.4× 234 0.9× 73 0.7× 82 0.8× 14 681
Marjo Tamminen Finland 11 533 1.7× 382 1.4× 78 0.3× 247 2.2× 118 1.1× 14 1.0k

Countries citing papers authored by Xiaofei Shao

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Shao more than expected).

Fields of papers citing papers by Xiaofei Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Shao. The network helps show where Xiaofei Shao may publish in the future.

Co-authorship network of co-authors of Xiaofei Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Shao. A scholar is included among the top collaborators of Xiaofei Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Shao. Xiaofei Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Luo, Yuxin, Sha Fu, Wenjuan Yu, et al.. (2024). Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis. BMC Nephrology. 25(1). 63–63. 7 indexed citations
3.
Zhou, Qin, Wenjuan Yu, Xiaofei Shao, et al.. (2023). #5705 EFFICACY AND SAFETY OF SACUBITRIL/VALSARTAN IN PATIENTS WITH STAGE 3B-5 CKD AND HYPERTENSION. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations
4.
Huang, Yuliang, et al.. (2023). #6496 CYCLIN D1 AMELIORATES ACUTE KIDNEY INJURY BY IMPROVING FATTY ACID OXIDATION VIA AMPK PATHWAY. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations
5.
Zhou, Qin, et al.. (2022). Amelioration of Renal Injury by Resveratrol in a Rat Renal Transplantation Model via Activation of the SIRT1/NF‐κB Signaling Pathway. BioMed Research International. 2022(1). 7140961–7140961. 6 indexed citations
6.
Shao, Xiaofei, et al.. (2022). Metabolic Syndrome Components and Chronic Kidney Disease in a Community Population Aged 40 Years and Older in Southern China: A Cross-Sectional Study. Diabetes Metabolic Syndrome and Obesity. Volume 15. 839–848. 6 indexed citations
7.
Han, Peipei, Peiyu Song, Jianying Niu, et al.. (2022). Mediating Effects of Malnutrition on the Relationship between Depressive Symptoms Clusters and Muscle Function Rather than Muscle Mass in Older Hemodialysis Patients. The journal of nutrition health & aging. 26(5). 461–468. 10 indexed citations
8.
Chen, Hui, et al.. (2020). Comparison of Novel Metabolic Indices in Estimation of Chronic Kidney Diseases in a Southern Chinese Population. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Wang, Xin, Haishan Chen, Xiaofei Shao, et al.. (2020). <p>Association of Lipid Parameters with the Risk of Chronic Kidney Disease: A Longitudinal Study Based on Populations in Southern China</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 663–670. 10 indexed citations
10.
Chen, Tong, Xuan Wang, Xin Wang, et al.. (2020). <p>Comparison of Novel Metabolic Indices in Estimation of Chronic Kidney Diseases in a Southern Chinese Population</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 4919–4927. 14 indexed citations
11.
Chen, Haishan, Chongxiang Xiong, Xiaofei Shao, et al.. (2019). <p>Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 2117–2123. 43 indexed citations
12.
Xia, Yue, Qin Zhou, Xin Wang, et al.. (2019). Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats. Transplant Immunology. 54. 20–28. 16 indexed citations
13.
Xia, Yue, et al.. (2018). Expression and significance of Sirt1 in renal allografts at the early stage of chronic renal allograft dysfunction. Transplant Immunology. 48. 18–25. 8 indexed citations
14.
Li, Yongqiang, et al.. (2018). Identification of chronic kidney disease risk in relatively lean Southern Chinese: the hypertriglyceridemic waist phenotype vs. anthropometric indexes. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 23(6). 885–892. 6 indexed citations
15.
16.
Zou, Zhihong Zhao, Shuangshuang Zhu, et al.. (2016). Correlation of visceral adiposity index with chronic kidney disease in the People&rsquo;s Republic of&nbsp;China: to rediscover the new clinical potential of an old indicator for visceral obesity. Therapeutics and Clinical Risk Management. 12. 489–489. 16 indexed citations
17.
Chen, Shanying, Xinyu Liu, Yan Liang, et al.. (2015). Association between Lipid Ratios and Insulin Resistance in a Chinese Population. PLoS ONE. 10(1). e0116110–e0116110. 40 indexed citations
18.
Li, Yongqiang, Xiaofei Shao, Xinyu Liu, et al.. (2014). Hypertriglyceridemic Waist Phenotype and Chronic Kidney Disease in a Chinese Population Aged 40 Years and Older. PLoS ONE. 9(3). e92322–e92322. 21 indexed citations
19.
Gu, Dongfeng, Youming Chen, Hongmei Liu, et al.. (2013). Prevalence of chronic kidney disease and prediabetes and associated risk factors: a community-based screening in Zhuhai, Southern China. Chinese Medical Journal. 126(7). 1213–1219. 16 indexed citations
20.
Chen, Shanying, Youming Chen, Xinyu Liu, et al.. (2013). Association of Insulin Resistance with Chronic Kidney Disease in Non-Diabetic Subjects with Normal Weight. PLoS ONE. 8(9). e74058–e74058. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lilin Gong Breakdown of academic impact, for papers by Jae Hwan Jee Breakdown of academic impact, for papers by Ei-Ichi Toda Breakdown of academic impact, for papers by Erdim Sertoğlu Breakdown of academic impact, for papers by Yiting Xu Breakdown of academic impact, for papers by Federica Piani Breakdown of academic impact, for papers by Ting Luo Breakdown of academic impact, for papers by Jenie Yoonoo Hwang Breakdown of academic impact, for papers by Ihab Wahba Breakdown of academic impact, for papers by Marjo Tamminen
Rankless by CCL
2026